CSIMarket Company Name, Ticker, Competitors, else..
 
Checkpoint Therapeutics inc   (NASDAQ: CKPT)
 

Checkpoint Therapeutics Inc's Suppliers Performance

CKPT's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CKPT Costs vs Sales of Suppliers Growth

• More on CKPT Suppliers






Checkpoint Therapeutics Inc's Comment on Supply Chain


The company intends to engage backup suppliers for its products and product candidates when possible but anticipates relying on a single contract manufacturer for each product due to long lead times and associated costs. These third-party manufacturers have limited facilities and experience in producing commercial-scale quantities and may have other clients and priorities that could impact their performance. Contract manufacturers are subject to inspections by the FDA, DEA, and state agencies to ensure compliance with cGMP and other regulations. Non-compliance may result in product recalls, inventory destruction, production stoppages, and supply disruptions. Changing manufacturers requires regulatory approval and may cause significant delays. The company does not have direct control over the compliance of third-party manufacturers beyond contractual obligations.

Checkpoint Therapeutics Inc's Comment on Supply Chain


The company intends to engage backup suppliers for its products and product candidates when possible but anticipates relying on a single contract manufacturer for each product due to long lead times and associated costs. These third-party manufacturers have limited facilities and experience in producing commercial-scale quantities and may have other clients and priorities that could impact their performance. Contract manufacturers are subject to inspections by the FDA, DEA, and state agencies to ensure compliance with cGMP and other regulations. Non-compliance may result in product recalls, inventory destruction, production stoppages, and supply disruptions. Changing manufacturers requires regulatory approval and may cause significant delays. The company does not have direct control over the compliance of third-party manufacturers beyond contractual obligations.







CKPT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Checkpoint Therapeutics inc 254.85 0.36 -56.51 19
SUBTOTAL 0.00 0.00 0.00 -


Sources: Checkpoint Therapeutics inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Checkpoint Therapeutics inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.